LENSAR Inc (LNSR)
3.00
-0.24
(-7.41%)
USD |
NASDAQ |
Apr 29, 16:00
3.04
+0.04
(+1.33%)
After-Hours: 20:00
LENSAR Revenue (Quarterly): 12.10M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.10M |
| September 30, 2023 | 9.795M |
| June 30, 2023 | 12.01M |
| March 31, 2023 | 8.252M |
| December 31, 2022 | 10.23M |
| September 30, 2022 | 7.748M |
| June 30, 2022 | 8.038M |
| March 31, 2022 | 9.34M |
| December 31, 2021 | 11.22M |
| Date | Value |
|---|---|
| September 30, 2021 | 8.272M |
| June 30, 2021 | 7.922M |
| March 31, 2021 | 7.043M |
| December 31, 2020 | 8.284M |
| September 30, 2020 | 7.145M |
| June 30, 2020 | 5.047M |
| March 31, 2020 | 5.906M |
| December 31, 2019 | 8.46M |
| September 30, 2019 | 8.068M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.047M
Minimum
Jun 2020
12.10M
Maximum
Dec 2023
8.605M
Average
8.262M
Median
Revenue (Quarterly) Benchmarks
| Ainos Inc | 0.0199M |
| OpGen Inc | 0.699M |
| Zomedica Corp | 7.337M |
| Eargo Inc (DELISTED) | 8.27M |
| Intelligent Bio Solutions Inc | 0.7641M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.926M |
| Total Expenses (Quarterly) | 15.07M |
| EPS Diluted (Quarterly) | -0.35 |
| Enterprise Value | 10.12M |
| Gross Profit Margin (Quarterly) | 42.54% |
| Profit Margin (Quarterly) | -32.43% |
| Earnings Yield | -59.67% |
| Normalized Earnings Yield | -47.20 |